← Back to headlines
Galapagos Partners with Gilead on Gamgertamig, Secures $500M
Galapagos has announced a partnership with Gilead on the drug Gamgertamig, a deal that unlocks $500 million in cash and sets sights on registrational trials by 2027.
31 Mar, 13:26 — 31 Mar, 13:26
Sources
Showing 1 of 1 sources
